Immuneering Corp
Immuneering Corp (IMRX) Option Chain
As of September 17, 2026, Immuneering Corp is trading at $4.46, a +0.23% change from the previous close. The nearest expiration is Sep 18, 2026. Implied volatility is 62.7%. IV Rank is —%.
Read more
Tracking the IMRX option chain helps you see every strike and expiry on Immuneering Corp in one view, so you can quickly identify the contracts that fit your thesis and your risk. Immuneering Corp's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of IMRX options activity at a glance. Use our scanner to monitor the IMRX option chain in real time and filter for the IMRX options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For IMRX stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the IMRX option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where IMRX stock options are being actively traded and where they are not.
Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to treat solid tumors. The company also has five oncology programs in the discovery stage that are designed to target components of the MAPK or mTOR pathway; and two discovery stage neuroscience programs. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts.
Immuneering Corporation was a former subsidiary of Teva Pharmaceutical Industries Limited.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Immuneering Corp's full chain across every expiry, highlights the most liquid strikes, and lets you screen IMRX options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of IMRX stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile—
- Market cap (M$)289
- 52 weeks high-55.75%
- 52 weeks low15.54%
- Analyst recommendationStrong Buy
1.00 - Target price$17.17
284.98% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-11
- P/E—
- Future P/E—
- EPS (ttm)-1.03
- EPS growth next 5 years3.70%
As of September 17, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 0.00 | 33 | 30 | -0.11 | 1.96 | 1.40 | 2.30 | 2.50 | -43.95 | — | 1.05 | 0.00 | 1.05 | 0 | 0 | 100.00 |
| 100.00 | 1,747 | 0 | 0.05 | 0.00 | — | 0.05 | 5.00 | +12.11 | — | 0.80 | 0.54 | 0.26 | 0 | 393 | 0.00 |
| 100.00 | 595 | 0 | 0.55 | 0.00 | — | 0.55 | 7.50 | +68.16 | 0.50 | 5.50 | 3.04 | -0.04 | 0 | 0 | 0.00 |
| 100.00 | 0 | 0 | 0.75 | 0.00 | — | 0.75 | 10.00 | +124.22 | 3.00 | 8.00 | 5.54 | -0.04 | 0 | 0 | 0.00 |
As of September 17, 2026
Scan the full option chain in one place
Browse the full IMRX option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→